Stage
No active trials
Next date
None yet
Trials
0 active
5 in total
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “Study Part 1: Randomized, double-blind, cross-over study with IB1001 and nonacog alfa; Study Part 2: Non-randomized, open-label evaluation of prophylaxis and on demand IB1001; Surgical Sub-study: Open-label evaluation of IB1001 during major surgery”In the company’s words, NCT00768287 on ClinicalTrials.gov
- Tested for
- Hemophilia B (2 trials), Niemann-Pick Disease, Type C, GM2 Gangliosidosis, Tay-Sachs Disease, Sandhoff Disease, Ataxia Telangiectasia
- Main trialPhase 3
- “The Study's Primary Objective is to evaluate the pharmacokinetics, safety (acute effects associated with infusions, and inhibitor development) and efficacy (breakthrough bleeding and control of hemorrhaging during prophylaxis) of IB1001 in previously treated pediatric subjects with hemophilia B.”In the company’s words, NCT01271868 on ClinicalTrials.gov
- Other names
- N-Acetyl-L-Leucine · IXINITY · Recombinant factor IX
Other drugs for Hemophilia B
- SR604Shanghai RAAS Blood Products Co., Ltd. · Phase 3
- MARSTACIMABPfizer · Phase 3
- PF-06838435Pfizer · Phase 3
- AskBio009Takeda · Phase 1/2
- LNP1265Regeneron · Phase 1/2
- REGV131Regeneron · Phase 1/2
Coming up0
No dates coming up.
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials5
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 3Terminated | Dec 2016 | Study of Recombinant Factor IX Product, IB1001, in Previously Treated Pediatric Subjects With Hemophilia B | |
| Phase 2/3Completed | Mar 2013 | Study of Recombinant Factor IX Product, IB1001, in Subjects With Hemophilia B | |
| Phase 2Completed | 7 Nov 2022 | N-Acetyl-L-Leucine for Niemann-Pick Disease, Type C (NPC) | |
| Phase 2Completed | 9 Jan 2023 | N-Acetyl-L-Leucine for GM2 Gangliosidosis (Tay-Sachs and Sandhoff Disease) | |
| Phase 2Terminated | 11 Feb 2025 | N-Acetyl-L-Leucine for Ataxia-Telangiectasia (A-T) |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026